Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News SPDR Bloomberg International Corporate Bond ETF IBND

SPDR Series Trust - SPDR Bloomberg International Corporate Bond ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in the fixed income markets of global ex-US region. The fund invests in fixed rate investment grade corporate bonds that are rated Baa3 or higher by Moody’s or BBB- or higher by S&P or Fitch... see more

Current News (ARCA:IBND)

No current news is available.
View More News ››

Opinion & Analysis (ARCA:IBND)

No current opinion is available.
View More Opinion ››

Bullboard Posts (ARCA:IBND)

Be the first to post on this bullboard.

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms ...
View More »

Podcasts